We are live on ! Find out more
RNLX

Renalytix plc American Depositary Shares

Delisted

RNLX was delisted on the 7th of October, 2024.

18 hedge funds and large institutions have $7.96M invested in Renalytix plc American Depositary Shares in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more capital invested

Capital invested by funds: $6.46M → $7.96M (+$1.5M)

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

9% more call options, than puts

Call options by funds: $51K | Put options by funds: $47K

18% less funds holding

Funds holding: 2218 (-4)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

Holders
18
Holders Change
-4
Holders Change %
-18.18%
% of All Funds
0.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
6
Reduced
5
Closed
7
Calls
$51K
Puts
$47K
Net Calls
+$4K
Net Calls Change
+$21K

RNLX Hedge Fund Activity: Q1 2023 in Review

18 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Renalytix plc American Depositary Shares (RNLX) for Q1 2023, worth a combined $7.96M — up 23% from $6.46M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of RNLX and 4 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 6 added.

The largest buyer was Pinnacle Associates, adding an estimated $644K. The largest seller was Pentwater Capital Management, cutting an estimated $277K.

  • 18 institutional investors held Renalytix plc American Depositary Shares (RNLX) as of Q1 2023, down from 22 in Q4 2022.
  • Funds reported $7.96M of Renalytix plc American Depositary Shares stock for Q1 2023, up 23% quarter-over-quarter.
  • 4 funds opened new Renalytix plc American Depositary Shares positions in Q1 2023 and 7 closed out, a net change of -3 holders.
  • The largest Renalytix plc American Depositary Shares buyer in Q1 2023 was Pinnacle Associates, an estimated $644K added.
  • The largest Renalytix plc American Depositary Shares seller in Q1 2023 was Pentwater Capital Management, an estimated $277K sold.

Based on aggregated 13F filings for Q1 2023.